Skip to main content

Jennifer Xu

Analyst

Cantor Fitzgerald

Equibles does not estimate personal net worth.

About Jennifer Xu

Jennifer Xu is recorded as Analyst at Cantor Fitzgerald. Jennifer Xu has spoken on 3 earnings calls across 3 companies, most recently for Arrowhead Pharmaceuticals, Inc. on August 4, 2026. Those appearances were for Arrowhead Pharmaceuticals, Inc. (ARWR), Ardelyx, Inc. (ARDX) and BlackRock, Inc. (BLK). The companies whose calls Jennifer Xu spoke on are classified in the Healthcare and Financial Services sectors.

Jennifer Xu on recent calls

“Just the first one is on Redemplo and SHTG. Just curious if you guys have a view on which TG responder analysis you view as maybe more important for establishing that Redemplo is a, you know, very strong TG lowering.”
Analyst — Cantor Fitzgerald, Arrowhead Pharmaceuticals, Inc. Q3 FY2026 Earnings Call ·
“Can you talk about the IBSC market where you're finding the greatest opportunity, and what is driving the market growth of double-digit, and how long do you think it's sustainable?”
Analyst — Cantor Fitzgerald, Ardelyx, Inc. Q4 FY2025 Earnings Call ·
“At this time, I'd like to welcome everyone to the BlackRock Incorporated Fourth Quarter 2025 Earnings Teleconference. Our host for today's call will be Chairman and Chief Executive Officer Lawrence D. Think, Chief Financial Officer Martin S. Small, President Robert Escapito, and General Counsel Christopher J. Meade.”
Conference Facilitator, Q4 2025 BlackRock, Inc. Earnings Conference Call ·

Affiliation history

  • Cantor Fitzgerald

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity